We appreciate the authors' input. Most important, reference 19 was erroneously switched in our manuscript with an article that was excluded. Both studies were written by authors named Kim, published in 2007. The reference you question from Kim BM et al was not included in the data used in our analysis because it did not, as you point out, meet the inclusion criteria. A report by Kim YJ did meet the inclusion criteria and was included in our analysis. This article should replace reference 19 in our references section:
19. Kim YJ. Early experiences of Neuroform stent-assisted coiling in ruptured intracranial aneurysms. Interv Neuroradiol 2007;13:31–44
The report by Yahia et al does include 5 ruptured aneurysms. In 1 patient, a recurrent aneurysm was also ruptured as indicated in the last paragraph of the “Results” section of that article. This patient did not have a complication related to stent-assisted coiling and does not change the outcome of our analysis if removed from the data.
We agree with your point that 6 patients reported by Tumialan et al did have antiplatelet therapy before undergoing common femoral artery sheath placement. This is discrepant with our statement that “None of the patients received antiplatelet therapy or heparin before the procedure.” However, this was an observation and not an inclusion criterion. Most of the patients (326 of 329) in our analysis did receive dual antiplatelet therapy, administered at various times. Furthermore, the report of Tumialan et al only includes 6 patients, none of whom had reported intraprocedural complications. The timing of administration of dual antiplatelet therapy, therefore, is not material for these patients and does not change our conclusions.